Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer
US9377474B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2015 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | May 22, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4721
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumor marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.